MedPath

Randomized double blind placebo-controlled intervention study to investigate effects of VITACEL extrinsic wheat fibers for maintenance of normal defecation by increasing fecal bulk in healthy subjects

Phase 3
Conditions
Regular digestion
Registration Number
DRKS00026262
Lead Sponsor
J. Rettenmaier & Söhne GmbH + Co KG
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
64
Inclusion Criteria

Good physical and mental health, stool frequency between 4 and 7 movements per week, BMI between 19 and 32 kg/m2, non-smoker, written consent to participate in the study

Exclusion Criteria

Mediacal disorders interfering with the study, subjects under prescription for medication or taking dietary supplements possibly interfering with this study, prior abdominal surgery, intake of antibiotics in the last 3 months prior to screening, use of pre- and probiotic supplements, subjects consuming food or drinks claimed as 'probiotic' or 'prebiotic', food or dinks claimed rich in fiber', more than 3 portions of fruits and vegetables (sum) per day, vegans and vegetarians, regular laxative use, regular stool consistency of diarrheal subtype

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Fecal bulk; collection with a fecontainer and weighing with a digital scale over three weeks
Secondary Outcome Measures
NameTimeMethod
Stool frequency; app-based documentation of the stool frequency
© Copyright 2025. All Rights Reserved by MedPath